ANI Pharmaceuticals, Inc. 2022-02-23 Health serious FDA
Health · FDA · Recall #FDA-D-0564-2022
Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b)… Recall
Issued February 23, 2022 · ANI Pharmaceuticals, Inc.
In February 2022, ANI Pharmaceuticals, Inc. recalled the Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b)…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
cGMP Deviations
What you should do
- 1 Stop using Alprazolam Tablets, USP 0.25 mg, packaged in a) 100-count bottles (NDC 67253-900-10), b)… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact ANI Pharmaceuticals, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- ANI Pharmaceuticals, Inc.
- Category
- Health
- Recall date
- February 23, 2022
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0564-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- ANI Pharmaceuticals, Inc. has 2 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.